MRKR insider trading

Open-market stock trades by Marker Therapeutics (MRKR) executives and directors: who bought or sold, how many shares, at what price and when.

MRKR insider trades

DateInsiderRoleTradeSharesPriceValue
Dec 23, 2024ELMS STEVEdirectorBuy11,085$3.20$35.47K
Dec 23, 2024New Enterprise Associates 16, L.P.10 percent ownerBuy554,250$3.20$1.77M
Mar 16, 2021Eansor Norman DaviddirectorBuy14,285$17.50$249.99K
May 18, 2021Wasserman Frederick GeralddirectorBuy10,000$2.41$24.10K
Mar 16, 2021Walker Paul Edward10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Sonsini Peter W.10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021SANDELL SCOTT D10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021MAKOWER JOSHUA10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Makhzoumi Mohamad10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Florence Anthony A. Jr.10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Chang Carmen10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Behbahani Ali10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021BASKETT FOREST10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021New Enterprise Associates 16, L.P.10 percent ownerBuy5,714,285$1.75$10.00M
Mar 16, 2021Wilson John RobertdirectorBuy1,714,285$1.75$3.00M
Mar 16, 2021Vera JuanChief Development OfficerBuy571,428$1.75$1000.00K
Mar 16, 2021Hoang Peter L.President and CEOBuy142,857$1.75$250.00K
Mar 16, 2021ELMS STEVEdirectorBuy1,142,857$1.75$2.00M

Updated 2026-11-20 21:45 UTC